SVB Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Sell
57,918
-1,660
-3% -$95.3K 0.21% 94
2026
Q1
$3.61M Sell
59,578
-2,417
-4% -$141K 0.24% 91
2025
Q4
$3.34M Sell
61,995
-9,404
-13% -$452K 0.2% 99
2025
Q3
$3.22M Buy
71,399
+5,038
+8% +$235K 0.17% 110
2025
Q2
$3.07M Buy
+66,361
New +$3.26M 0.16% 123
2025
Q1
Sell
-87,294
Closed -$4.94M 1525
2024
Q4
$4.94M Buy
+87,294
New +$4.88M 0.09% 142
2024
Q3
Sell
-86,707
Closed -$3.6M 93
2024
Q2
$3.6M Sell
86,707
-7,272
-8% -$325K 0.09% 178
2024
Q1
$5.1M Buy
93,979
+536
+0.6% +$27.3K 0.11% 163
2023
Q4
$4.79M Buy
93,443
+367
+0.4% +$19.3K 0.12% 167
2023
Q3
$5.4M Sell
93,076
-11,731
-11% -$719K 0.12% 146
2023
Q2
$6.7M Sell
104,807
-9,827
-9% -$659K 0.12% 142
2023
Q1
$7.95M Sell
114,634
-8,773
-7% -$619K 0.11% 140
2022
Q4
$8.88M Sell
123,407
-14,410
-10% -$1.09M 0.12% 127
2022
Q3
$9.8M Buy
137,817
+12,760
+10% +$926K 0.14% 116
2022
Q2
$9.63M Buy
125,057
+1,191
+1% +$90.7K 0.15% 108
2022
Q1
$9.04M Sell
123,866
-1,087
-0.9% -$73K 0.12% 121
2021
Q4
$7.79M Sell
124,953
-2,719
-2% -$159K 0.13% 120
2021
Q3
$7.55M Sell
127,672
-2,951
-2% -$194K 0.1% 136
2021
Q2
$8.73M Sell
130,623
-2,245
-2% -$146K 0.11% 125
2021
Q1
$8.39M Buy
132,868
+1,491
+1% +$92.8K 0.12% 121
2020
Q4
$8.15M Sell
131,377
-8,677
-6% -$534K 0.12% 123
2020
Q3
$8.44M Sell
140,054
-1,492
-1% -$89.8K 0.14% 106
2020
Q2
$8.32M Sell
141,546
-2,505
-2% -$150K 0.15% 102
2020
Q1
$8.03M Sell
144,051
-8,705
-6% -$532K 0.19% 82
2019
Q4
$9.8M Buy
152,756
+52,233
+52% +$2.99M 0.18% 97
2019
Q3
$5.1M Sell
100,523
-4,858
-5% -$228K 0.1% 130
2019
Q2
$4.78M Sell
105,381
-936
-0.9% -$43.6K 0.16% 133
2019
Q1
$5.07M Sell
106,317
-37,065
-26% -$1.85M 0.2% 101
2018
Q4
$7.45M Sell
143,382
-2,352
-2% -$126K 0.32% 87
2018
Q3
$9.05M Sell
145,734
-4,922
-3% -$292K 0.32% 91
2018
Q2
$8.34M Sell
150,656
-3,080
-2% -$166K 0.32% 89
2018
Q1
$9.72M Sell
153,736
-9,858
-6% -$634K 0.37% 83
2017
Q4
$10M Sell
163,594
-4,164
-2% -$260K 0.38% 84
2017
Q3
$10.7M Sell
167,758
-1,948
-1% -$114K 0.41% 80
2017
Q2
$9.46M Sell
169,706
-12,734
-7% -$693K 0.37% 83
2017
Q1
$9.92M Sell
182,440
-45,735
-20% -$2.51M 0.4% 78
2016
Q4
$13.3M Sell
228,175
-45,121
-17% -$2.47M 0.55% 58
2016
Q3
$14.7M Buy
273,296
+24,208
+10% +$1.56M 0.6% 58
2016
Q2
$18.3M Sell
249,088
-32,869
-12% -$2.32M 0.75% 44
2016
Q1
$18M Buy
281,957
+13,407
+5% +$845K 0.73% 47
2015
Q4
$18.5M Sell
268,550
-17,448
-6% -$1.15M 0.73% 40
2015
Q3
$16.9M Sell
285,998
-8,166
-3% -$518K 0.66% 49
2015
Q2
$19.6M Sell
294,164
-14,092
-5% -$929K 0.65% 44
2015
Q1
$19.8M Sell
308,256
-2,700
-0.9% -$169K 0.64% 51
2014
Q4
$18.4M Buy
+310,956
New +$17.5M 0.59% 56

Other funds holding BMY

SVB Wealth's BMY Position: Q2 2026 in Review

SVB Wealth reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $95.3K and leaving 57,918 shares worth $3.34M. The position accounts for 0.21% of the portfolio, ranked #94.

SVB Wealth first reported a position in BMY in Q4 2014 and has held it in 45 quarters since. The position peaked at $19.8M in Q1 2015. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • SVB Wealth held 57,918 shares of Bristol-Myers Squibb worth $3.34M as of Q2 2026.
  • SVB Wealth sold 1,660 Bristol-Myers Squibb shares in Q2 2026, an estimated $95.3K.
  • Bristol-Myers Squibb made up 0.21% of SVB Wealth's portfolio in Q2 2026, its #94 holding.
  • SVB Wealth first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 45 quarters since.
  • SVB Wealth's Bristol-Myers Squibb position peaked at $19.8M in Q1 2015.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on SVB Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.